SCHEMBL9499648

SCHEMBL9499648

CCOP(=O)(Cc1ccc(C(=O)Nc2ccc(C)cc2)cc1)OCC

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.59
RAB9A P51151 7/20 0.59
GAA P10253 2/20 0.52
NPSR1 Q6W5P4 1/20 0.52
SMN1; SMN2 Q16637 5/20 0.51
MAPT P10636 2/20 0.51
LMNA P02545 2/20 0.50
ENPP1 P22413 1/20 0.50
HDAC1 Q13547 1/20 0.48
CCR5 P51681 2/20 0.48
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
USP2 O75604 1/20 0.47
POLB P06746 1/20 0.47
NAMPT P43490 1/20 0.47
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7164864 0.88 NPC1 (0.52) NPC1RAB9AGAASMN1; SMN2MAPT
SCHEMBL9502383 0.88 HDAC1 (0.50) NPC1RAB9AGAASMN1; SMN2MAPT
SCHEMBL9502356 0.88 MAPT (0.55) NPC1GAASMN1; SMN2MAPTLMNA
SCHEMBL9500932 0.88 RAB9A (0.58) NPC1RAB9AGAAMAPTLMNA
SCHEMBL8537002 0.88 TRPV1 (0.58) NPC1RAB9AGAASMN1; SMN2HDAC1
SCHEMBL9500132 0.87 NPC1 (0.65) NPC1RAB9AGAASMN1; SMN2MAPT
SCHEMBL9499536 0.86 TRPV1 (0.57) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL9500191 0.85 MLYCD (0.51) NPC1RAB9ASMN1; SMN2MAPTHDAC1
SCHEMBL19331999 0.84 NPY5R (0.48) NPC1RAB9AGAASMN1; SMN2HDAC1
SCHEMBL9499597 0.84 LMNA (0.66) NPC1RAB9ASMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0273444-B1 USE OF CARBOXAMIDE COMPOUNDS FOR THE PREPARATION OF A MEDICAMENT FOR TREATING HYPERLIPIDEMIA OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1993-05-05 EP claimed
US-5081112-A Administering an aryl phosphonate carboxamide OTSUKA PHARMACEUTICAL FACTORY INC. (JP) 1992-01-14 US claimed
EP-0273444-A2 Use of carboxamide compounds for the preparation of a medicament for treating hyperlipidemia OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1988-07-06 EP claimed
EP-0273444-B1 USE OF CARBOXAMIDE COMPOUNDS FOR THE PREPARATION OF A MEDICAMENT FOR TREATING HYPERLIPIDEMIA OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1993-05-05 EP disclosed
US-5081112-A Administering an aryl phosphonate carboxamide OTSUKA PHARMACEUTICAL FACTORY INC. (JP) 1992-01-14 US disclosed
EP-0273444-A2 Use of carboxamide compounds for the preparation of a medicament for treating hyperlipidemia OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1988-07-06 EP disclosed